Evidence map›Paper›PMID 38143448›Full record

ArticleFrontiers in medicine2023

Corrigendum: Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers-Danlos syndrome.

Antonio Bulbena, Silvia Rosado, Marina Cabaleiro, María Martinez, Carolina Baeza-Velasco, Luis-Miguel Martin, Santiago Batlle, Andrea Bulbena-Cabré

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Antonio BulbenaDepartment of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain.
Silvia RosadoAnxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain.
Marina CabaleiroDepartment of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain.
María MartinezDepartment of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain.
Carolina Baeza-VelascoLaboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, Paris, France.
Luis-Miguel MartinAnxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain.
Santiago BatlleAnxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain.
Andrea Bulbena-CabréIcahn School of Medicine, Mount Sinai, New York, NY, United States.
Hospital Del Mar · ESCentro de Investigación Biomédica en Red de Salud Mental · ESIcahn School of Medicine at Mount Sinai · USInserm · FRUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2023.1039223.].

Indexed as

anxietyEhlers-Danlos syndromejoint hypermobilityneuroconnective endophenotypepsychosomatic medicinereliabilityvalidity

Identifiers

PMID38143448
PMCPMC10740201
OpenAlexW4389434637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.